2026.03 Promotion homepage banner (2)
Homepage banner--Transcriptomics
Homepage banner-- Revio
banner

Explore Our Main Services

BMKGENE provides ONE-STOP solutions on multi-omics levels that fulfill diverse research goals
GENOMICS

GENOMICS

WGS/RRGS/WES sequencing for animal, plant and human samples, enabling variant identification and de novo genome assembly to meet comprehensive genomic research needs.
GENOMICS

GENOMICS

Leam More

MICROBIAL <br> GENOMICS

MICROBIAL
GENOMICS

Single strains or microbial communities, whole-genome resequencing or de novo sequencing, meeting all microbial genomics research needs
MICROBIAL <br> GENOMICS

MICROBIAL
GENOMICS

Leam More

TRANSCRIPT-<br>OMICS

TRANSCRIPT-
OMICS

mRNA, IncRNA, sRNA, circRNA, whole transcriptome sequencing, unveiling the RNA world comprehensively by NGS and TGS
TRANSCRIPT-<br>OMICS

TRANSCRIPT-
OMICS

Leam More

SINGLE-CELL<br> OMICS

SINGLE-CELL
OMICS

High-resolution single-cell and spatial transcriptomics platforms to dissect cellular heterogeneity and explore tissue architecture
SINGLE-CELL<br> OMICS

SINGLE-CELL
OMICS

Leam More

EPIGENETICS

EPIGENETICS

State-of-the-art technologies for mapping epigenetic modifications to elucidate gene regulatory mechanisms
EPIGENETICS

EPIGENETICS

Leam More

BMKCLOUD

BMKCLOUD

Self-developed powerful bioinformatics platform, covering mainstream bioinformatic analysis apps in genomics, transcriptomics, microbial genomics, and more
BMKCLOUD

BMKCLOUD

Leam More

BMKGENE

view more

BMKGENE is a globally recognized leader in genomics services. For over 17 years, the company has been at the forefront of innovation, pioneering advancements in high-throughput sequencing technologies and bioinformatics. Backed by a dedicated and highly skilled R&D team, BMKGENE delivers cutting-edge, comprehensive sequencing solutions spanning genomics, transcriptomics, single-cell omics, and epigenetics, empowering breakthroughs in life sciences research.

Our Platform
Our Mission
BMKCLOUD

why choose BMKGENE

  • Our Platform
  • Our Mission
  • BMKCLOUD
Our Platform: BMKGENE boasts state-of-the-art infrastructure, integrating cutting-edge high-throughput sequencing platforms and robust high-performance computing systems to deliver comprehensive solutions across next-generation sequencing (NGS), third-generation sequencing (TGS), single-cell multiomics, proteomics, metabolomics, and large-scale data analytics. Our capabilities are anchored by three core pillars:
 
 
  • – Featuring NGS and third-generation technologies for precision and scalability。
  • – Streamlining workflows with professional-grade automation and stringent quality standards.
  • – Empowering seamless, AI-driven data analysis and visualization for global clients.

Biomarker Technologies is dedicated to advancing genetic innovation that transforms industries and elevates human welfare. Through cutting-edge biotechnology solutions, we strive to pioneer sustainable progress while maintaining an unwavering commitment to creating exceptional value for our partners. Our vision extends beyond commercial success – we aim to establish a global innovation hub that redefines standards in the bio-industry and leaves an enduring legacy of scientific advancement.

To pioneer revolutionary biotechnology breakthroughs

To empower societal progress through science

To enhance human well-being with genetic solutions

To build an iconic bio-enterprise ecosystem

To establish a world-class innovation center of excellence

Our world-class technical team excels at solving complex scientific and technical challenges, leveraging deep expertise across diverse research fields. With a proven track record of innovation, the team has published hundreds of high-impact studies in leading journals such as Nature, Nature Genetics, Plant Cell, and Nature Communications. Additionally, we hold 60+ national invention patents and 200+ software copyrights, reflecting our commitment to advancing technology and intellectual leadership.

Science and Technology Services: Tailored solutions for cutting-edge research and industrial applications.

Online Bioinformatics Platform: An intuitive, user-friendly tool for genomic analysis, data visualization, and collaborative research.

Medical Technology Services: Specialized support for diagnostics, therapeutic development, and precision medicine.

WE'LL PROVIDE YOU PROFESSIONAL SERVICES

Professional Staff

0

Professional Staff

We boast a robust R&D team comprising over 500 highly skilled and educated technicians.

Software Copyrights

0

Software Copyrights

We possess over 200 software copyrights

Inventions Patents of Inventions

0

Inventions Patents of Inventions

We hold more than 60 patents for inventions.

Impact Factor

0+

Impact Factor

We have contributed to more than 1,000 high-impact published projects, showcasing our commitment to innovation and excellence.

News

  • BMKGENE Hong Kong Laboratory Relocates to HSITP with Major Upgrades

    Apr 09, 2026

    BMKGENE Hong Kong Laboratory Relocates to HSITP with Major Upgrades
  • BMKGENE Makes a Splash at PAG 33 Genomics Conference, with Lively On-site Interactions and Growing Collaborations

    Jan 12, 2026

    BMKGENE Makes a Splash at PAG 33 Genomics Conference, with Lively On-site Interactions and Growin...
  • BMKGENE Engages CANVAS 2025 Attendees with Multi-Omics Solutions for Agri-Environmental Science

    Nov 11, 2025

    BMKGENE Engages CANVAS 2025 Attendees with Multi-Omics Solutions for Agri-Environmental Science
VIEW ALL NEWS

Featured Publications

  • Featured Publication — Single-Cell Transcriptomic Atlases Reveal the Molecular Evolution of Digestive and Metabolic Systems in Camels and Cattle

    Jul 15, 2026

    Featured Publication — Single-Cell Transcriptomic Atlases Reveal the Molecular Evolution of...
  • Featured Publication — Decoding the Genomic Basis of Social Evolution in Woodroaches and Termites

    May 28, 2026

    Featured Publication — Decoding the Genomic Basis of Social Evolution in Woodroaches and Te...
  • Featured Publication — RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 inflammasome activation in an MPTP-induced parkinson’s disease mouse model

    May 18, 2026

    Featured Publication — RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 in...
VIEW ALL PUBLICATIONS

For inquiries about our products or pricelist, please leave your email to us.

We will be in touch within 24 hours.

Inquiry Now